(Q43246066)

English

Pharmacokinetics of CsA during the switch from continuous intravenous infusion to oral administration after allogeneic hematopoietic stem cell transplantation

scientific article published on 9 November 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Pharmacokinetics of CsA during the switch from continuous intravenous infusion to oral administration after allogeneic hematopoietic stem cell transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

S Kimura

1

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

K Oshima

2

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

S Okuda

3

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

K Sato

4

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

M Sato

5

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

K Terasako

6

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

H Nakasone

7

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

S Kako

8

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

R Yamazaki

9

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Y Tanaka

10

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

A Tanihara

11

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

T Higuchi

12

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

J Nishida

13

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Y Kanda

14

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

language of work or name

0 references

publication date

9 November 2009

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

45

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

1088-1094

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

https://scigraph.springernature.com/pub.10.1038/bmt.2009.316

0 references

Fludarabine, cyclophosphamide, anti-thymocyteglobulin, and low-dose total body irradiation conditioning enables 1-HLA-locus-mismatched hematopoietic stem cell transplantation for very severe aplastic anemia without affecting ovarian function

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.316

21 January 2018

Long-term ultra-low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.316

21 January 2018

Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in Japan

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.316

21 January 2018

Evaluation of appropriate blood level in continuous intravenous infusion from trough concentrations after oral administration based on area under trough level in tacrolimus and cyclosporine therapy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.316

21 January 2018

Drug interactions in the hematopoietic stem cell transplant (HSCT) recipient: what every transplanter needs to know

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.316

21 January 2018

Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.316

21 January 2018

Evaluation of the drug interaction between intravenous high-dose fluconazole and cyclosporine or tacrolimus in bone marrow transplant patients.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.316

21 January 2018

Greater impact of oral fluconazole on drug interaction with intravenous calcineurin inhibitors as compared with intravenous fluconazole

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.316

21 January 2018

Beneficial pharmacokinetic interaction between cyclosporine and itraconazole in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.316

21 January 2018

Pharmacokinetic evaluation of the drug interaction between intravenous itraconazole and intravenous tacrolimus or intravenous cyclosporin A in allogeneic hematopoietic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.316

21 January 2018

Drug interaction between voriconazole and calcineurin inhibitors in allogeneic hematopoietic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.316

21 January 2018

A survey of the prophylaxis and treatment of acute GVHD in Europe: a report of the European Group for Blood and Marrow, Transplantation (EBMT). Chronic Leukaemia Working Party of the EBMT

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.316

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of blood cyclosporine concentration on the outcome of hematopoietic stem cell transplantation from an HLA-matched sibling donor

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.316

7 January 2021

based on heuristic

inferred from DOI database lookup

Decreased incidence of acute graft-versus-host disease by continuous infusion of cyclosporine with a higher target blood level

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.316

7 January 2021

based on heuristic

inferred from DOI database lookup

New oral formulation of cyclosporin A (Neoral) pharmacokinetics in allogeneic bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.316

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of grapefruit juice on the pharmacokinetics of microemulsion cyclosporine and its metabolite in healthy volunteers: does the formulation difference matter?

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.316

7 January 2021

based on heuristic

inferred from DOI database lookup

Interaction between cyclosporine and fluconazole in renal allograft recipients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.316

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluconazole-cyclosporine interaction: a dose-dependent effect?

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.316

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose adjustment and cost of itraconazole prophylaxis in lung transplant recipients receiving cyclosporine and tacrolimus (FK 506)

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.316

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/BMT.2009.316

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43246066&oldid=2143612776"